Clinical trial
Observational Study About the Use of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245555 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study About the Use of Tamsulosin in Patients With Benign Prostatic Hyperplasia
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- Not reported
- Enrollment
- 1,060 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.